Out-licensing

Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More

Enhancing the dissolution performance of small and large molecules in a range of dosage forms More

Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More

For research and drug development for treatment of respiratory syncytial virus More

Vaccine strategy relates to the engineering and creation of live-attenuated RSV vaccine candidates by shifting the position of one or more viral genes relative to the viral promoter More

Chimeric human-bovine RSVs recombinantly engineered to incorporate nucleotide sequences from both human and bovine RSV strains and produce infectious, chimeric viruses that elicit anti-RSV immunological responses in humans and non-human primates. More